Myelodysplastic syndrome: an inability to appropriately respond to damaged DNA?
about
Defective control of pre-messenger RNA splicing in human diseasePotential relationship between inadequate response to DNA damage and development of myelodysplastic syndrome.Development of cancer-initiating cells and immortalized cells with genomic instability.Thrombopoietin promotes NHEJ DNA repair in hematopoietic stem cells through specific activation of Erk and NF-κB pathways and their target, IEX-1SRSF2 Is Essential for Hematopoiesis, and Its Myelodysplastic Syndrome-Related Mutations Dysregulate Alternative Pre-mRNA Splicing.Fucoidan inhibits proliferation of the SKM-1 acute myeloid leukaemia cell line via the activation of apoptotic pathways and production of reactive oxygen species.Haploinsufficiency of del(5q) genes, Egr1 and Apc, cooperate with Tp53 loss to induce acute myeloid leukemia in mice.Adult Stem Cells and Diseases of Aging.DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance.On the potential role of DNMT1 in acute myeloid leukemia and myelodysplastic syndromes: not another mutated epigenetic driver.Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome.Progressive genomic instability in the Nup98-HoxD13 model of MDS correlates with loss of the PIG-A gene productTelomeres and Telomerase in Hematopoietic Dysfunction: Prognostic Implications and Pharmacological Interventions.Differential expression of homologous recombination DNA repair genes in the early and advanced stages of myelodysplastic syndrome.MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine.The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations.
P2860
Q28077564-8D3B35D5-7B01-437A-AF23-553F124903D5Q35016534-E74473C2-208C-489A-AAF6-83E95DE3DC27Q35205699-46CD2119-4684-49C7-BC37-D895167E569EQ35743835-23D6AD87-8D83-432C-8F93-AB118FEB7648Q35917455-34CA1494-D75C-4F0D-8B19-BA97A2140775Q36225001-6072B0EA-6314-49DF-AA0A-0D3A3E36DB38Q37585218-9CCB1B82-13DE-4B8B-9BFD-DE852F21FC07Q37711264-041BB00F-BD33-4839-921E-2B638A62DC92Q38238954-A8F43C7F-D8E3-478B-834D-B62DA2C22FBCQ38777440-CA4DB52E-FC94-43CF-8FD4-4F02E8EC4FC3Q41191920-53B38D7A-2D21-4275-BFA0-570C54999D19Q42681933-B1D94DAC-997F-48C6-A3C4-EE31F4F4E082Q47612537-939C8F29-FDB6-4DD4-96A7-3B5676D10E41Q48169044-68B0E016-9B0D-4431-83B7-4DA4EA0BC793Q48181306-5F99DCF1-DA83-4A4D-8C14-5488A1167F62Q50209871-16ACF336-D455-4F11-88EE-0F357857AD81
P2860
Myelodysplastic syndrome: an inability to appropriately respond to damaged DNA?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Myelodysplastic syndrome: an inability to appropriately respond to damaged DNA?
@en
Myelodysplastic syndrome: an inability to appropriately respond to damaged DNA?
@nl
type
label
Myelodysplastic syndrome: an inability to appropriately respond to damaged DNA?
@en
Myelodysplastic syndrome: an inability to appropriately respond to damaged DNA?
@nl
prefLabel
Myelodysplastic syndrome: an inability to appropriately respond to damaged DNA?
@en
Myelodysplastic syndrome: an inability to appropriately respond to damaged DNA?
@nl
P2093
P2860
P1476
Myelodysplastic syndrome: an inability to appropriately respond to damaged DNA?
@en
P2093
Alexander J R Bishop
Christi A Walter
Linda M Scott
Paul Hasty
Vivienne I Rebel
P2860
P304
P356
10.1016/J.EXPHEM.2013.04.008
P577
2013-04-30T00:00:00Z